Cardiovascular Drugs and Therapy

, Volume 26, Issue 4, pp 359–360

New Challenges Ahead for the Newer Oral Thrombin Inhibitors that Aim at Replacing Warfarin in Clinical Practice—Any Role for Scientific Societies in the Debate?


DOI: 10.1007/s10557-012-6393-1

Cite this article as:
Kaski, JC. Cardiovasc Drugs Ther (2012) 26: 359. doi:10.1007/s10557-012-6393-1

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.St. George’s HospitalUniversity of LondonLondonUK